Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that the Center for Devices and Radiological Health (CDRH) ...
AI-manipulated news report: The ad used a news report taken from GMA’s 24 Oras October 15 newscast, manipulating it using ...
DCGI calls for meeting with stakeholders of cosmetics industry to discuss issues: Our Bureau, New Delhi Thursday, November 14, 2024, 08:00 Hrs [IST] The Drugs Controller General o ...
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...
Recently, news portal Malaysiakini released three pieces of “evidence” from a whistleblower, alleging that the government was involved in abuse of power and corruption. In one of the clips, Sindumin ...
Alvotech and Teva Pharmaceuticals announced that the U.S. FDA has approved a new presentation of SELARSDI ... Please visit our investor portal, and our website or follow us on social media on LinkedIn ...
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
Things are coming along well for the obesity treatment program of Pemvidutide as well, because the company has successfully ...
Chair of the Indonesian Ombudsman Mokhammad Najih has said that the quality of public services in 2024 has improved ...
Subject: Mandatory PAN Compliance for FSSAI License/Registration-reg.